These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
180 related articles for article (PubMed ID: 10762119)
1. Successful treatment of Castleman's disease with HAART in two HIV-infected patients. Lanzafame M; Carretta G; Trevenzoli M; Lazzarini L; Vento Ercole Concia S J Infect; 2000 Jan; 40(1):90-1. PubMed ID: 10762119 [TBL] [Abstract][Full Text] [Related]
2. Multicentric Castleman's disease in HIV infection: a systematic review of the literature. Mylona EE; Baraboutis IG; Lekakis LJ; Georgiou O; Papastamopoulos V; Skoutelis A AIDS Rev; 2008; 10(1):25-35. PubMed ID: 18385778 [TBL] [Abstract][Full Text] [Related]
3. Multicentric Castleman's disease in 2 patients with HIV infection, unresponsive to antiviral therapy. Bottieau E; Colebunders R; Schroyens W; Van Droogenbroeck J; De Droogh E; Depraetere K; De Raeve H; Van Marck E Acta Clin Belg; 2000; 55(2):97-101. PubMed ID: 10881375 [TBL] [Abstract][Full Text] [Related]
4. The role of immune suppression and HHV-8 in the increasing incidence of HIV-associated multicentric Castleman's disease. Powles T; Stebbing J; Bazeos A; Hatzimichael E; Mandalia S; Nelson M; Gazzard B; Bower M Ann Oncol; 2009 Apr; 20(4):775-9. PubMed ID: 19179554 [TBL] [Abstract][Full Text] [Related]
5. Multicentric Castleman's Disease and Kaposi's Sarcoma in a HIV-Positive Patient on Highly Active Antiretroviral Therapy. Ortega L; Cooper CJ; Otoukesh S; Mojtahedzadeh M; Didia CS; Torabi A; Nahleh Z Rare Tumors; 2014 Jul; 6(3):5480. PubMed ID: 25276327 [TBL] [Abstract][Full Text] [Related]
6. Cellular localisation of HHV-8 in Castleman's disease: is there a link with lymph node vascularity? O'Leary J; Kennedy M; Howells D; Silva I; Uhlmann V; Luttich K; Biddolph S; Lucas S; Russell J; Bermingham N; O'Donovan M; Ring M; Kenny C; Sweeney M; Sheils O; Martin C; Picton S; Gatter K Mol Pathol; 2000 Apr; 53(2):69-76. PubMed ID: 10889905 [TBL] [Abstract][Full Text] [Related]
7. Durable remission of both multicentric Castleman's disease and Kaposi's sarcoma with valganciclovir, rituximab and liposomal doxorubicin in an HHV-8-positive, HIV-negative patient. Murphy C; Hawkes E; Chionh F; Chong G J Clin Pharm Ther; 2017 Feb; 42(1):111-114. PubMed ID: 27790727 [TBL] [Abstract][Full Text] [Related]
8. Infection of mesothelial cells with human herpes virus 8 in human immunodeficiency virus-infected patients with Kaposi's sarcoma, Castleman's disease, and recurrent pleural effusions. Bryant-Greenwood P; Sorbara L; Filie AC; Little R; Yarchoan R; Wilson W; Raffeld M; Abati A Mod Pathol; 2003 Feb; 16(2):145-53. PubMed ID: 12591967 [TBL] [Abstract][Full Text] [Related]
10. Multicentric Castleman's disease in human immunodeficiency virus infection: two case reports. Caroline Ribeiro Sales A; Romão de Souza Junior V; Iglis de Oliveira M; Azevedo Braga Albuquerque C; de Barros Campelo Júnior E; Sérgio Ramos de Araújo P J Med Case Rep; 2018 May; 12(1):117. PubMed ID: 29728131 [TBL] [Abstract][Full Text] [Related]
11. Fifty years of multicentric Castleman's disease. Waterston A; Bower M Acta Oncol; 2004; 43(8):698-704. PubMed ID: 15764213 [TBL] [Abstract][Full Text] [Related]
12. [Castleman's disease in patients infected with HIV]. Aaron L; Lidove O; Viard JP; Troisvallet D; Piketty C; Vittecoq D; Zucman D; Blétry O; Dupont B Rev Med Interne; 2002 Feb; 23(2):155-63. PubMed ID: 11876059 [TBL] [Abstract][Full Text] [Related]
13. A case of multicentric Castleman's disease in HIV infection with the rare complication of acquired angioedema. Fernando I; Scott G Int J STD AIDS; 2014 Jun; 25(7):523-5. PubMed ID: 24352125 [TBL] [Abstract][Full Text] [Related]
14. The successful treatment of haemophagocytic syndrome in patients with human immunodeficiency virus-associated multi-centric Castleman's disease. Stebbing J; Ngan S; Ibrahim H; Charles P; Nelson M; Kelleher P; Naresh KN; Bower M Clin Exp Immunol; 2008 Dec; 154(3):399-405. PubMed ID: 19222502 [TBL] [Abstract][Full Text] [Related]
15. Simultaneous Kaposi's sarcoma and Castleman's disease in a HIV-negative patient. Response to rituximab and doxorubicin. García-Arpa M; Calle-Primo C; Martín-Dávila F Med Clin (Barc); 2020 Dec; 155(12):565-566. PubMed ID: 31759694 [No Abstract] [Full Text] [Related]
16. Increased expression of vascular endothelial growth factor (VEGF) in Castleman's disease: proposed pathomechanism of vascular proliferation in the affected lymph node. Nishi J; Maruyama I Leuk Lymphoma; 2000 Jul; 38(3-4):387-94. PubMed ID: 10830746 [TBL] [Abstract][Full Text] [Related]
18. Tropism of human herpesvirus 8 for peripheral blood lymphocytes in patients with Castleman's disease. Kikuta H; Itakura O; Taneichi K; Kohno M Br J Haematol; 1997 Dec; 99(4):790-3. PubMed ID: 9432023 [TBL] [Abstract][Full Text] [Related]
19. Highly active anti-retroviral therapy (HAART) prolongs time to treatment failure in Kaposi's sarcoma. Bower M; Fox P; Fife K; Gill J; Nelson M; Gazzard B AIDS; 1999 Oct; 13(15):2105-11. PubMed ID: 10546864 [TBL] [Abstract][Full Text] [Related]
20. Successful treatment of iatrogenic multicentric Castleman's disease arising due to recrudescence of HHV-8 in a liver transplant patient. Speicher DJ; Sehu MM; Mollee P; Shen L; Johnson NW; Faoagali JL Am J Transplant; 2014 May; 14(5):1207-13. PubMed ID: 24674650 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]